Centessa Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Centessa Pharmaceuticals plc (CNTA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.380.260.390.600.01
Short-Term Investments0.100.130.000.000.00
Cash & Short-Term Investments0.480.260.390.600.01
Accounts Receivable0.050.040.030.020.00
Inventory0.000.000.000.000.00
Other Current Assets0.000.040.000.000.00
Total Current Assets0.540.320.440.630.01
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.040.050.010.000.00
Total Assets0.580.360.440.630.01
Current Liabilities
Accounts Payable0.010.040.010.010.00
Accrued Liabilities0.040.030.020.020.00
Other Current Liabilities0.000.060.000.000.00
Total Current Liabilities0.060.040.040.020.01
Non-Current Liabilities
Long-Term Debt0.110.080.070.080.00
Other Non-Current Liabilities0.000.000.000.040.00
Total Non-Current Liabilities0.120.080.070.110.00
Total Liabilities0.180.120.110.140.01
Stockholders' Equity
Common Stock0.000.000.000.000.03
Retained Earnings-0.99-0.75-0.60-0.39-0.02
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital1.390.990.940.880.00
Shares Outstanding0.130.100.090.090.00
Total Stockholders' Equity0.400.240.340.490.00
Total Liabilities & Equity0.580.360.440.630.00